{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T16:10:56Z","timestamp":1792253456004,"version":"4.4.0"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"S7","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1038\/nm1066","type":"journal-article","created":{"date-parts":[[2004,7,22]],"date-time":"2004-07-22T10:13:27Z","timestamp":1090491207000},"page":"S10-S17","source":"Crossref","is-referenced-by-count":3089,"title":["Protein aggregation and neurodegenerative disease"],"prefix":"10.1038","volume":"10","author":[{"given":"Christopher A","family":"Ross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,7,1]]},"reference":[{"key":"BFnm1066_CR1","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1126\/science.1067122","volume":"296","author":"JP Taylor","year":"2002","unstructured":"Taylor, J.P., Hardy, J. & Fischbeck, K.H. Toxic proteins in neurodegenerative disease. Science 296, 1991\u20131995 (2002).","journal-title":"Science"},{"key":"BFnm1066_CR2","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/S0140-6736(03)13304-1","volume":"361","author":"G Bates","year":"2003","unstructured":"Bates, G. Huntingtin aggregation and toxicity in Huntington's disease. Lancet 361, 1642\u20131644 (2003).","journal-title":"Lancet"},{"key":"BFnm1066_CR3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1146\/annurev.neuro.26.010302.081142","volume":"26","author":"B Caughey","year":"2003","unstructured":"Caughey, B. & Lansbury, P.T. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci. 26, 267\u2013298 (2003).","journal-title":"Annu. Rev. Neurosci."},{"key":"BFnm1066_CR4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0959-437X(03)00053-4","volume":"13","author":"SJ Berke","year":"2003","unstructured":"Berke, S.J. & Paulson, H.L. Protein aggregation and the ubiquitin proteasome pathway: gaining the UPPer hand on neurodegeneration. Curr. Opin. Genet. Dev. 13, 253\u2013261 (2003).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"BFnm1066_CR5","doi-asserted-by":"crossref","unstructured":"Ross, C.A. & Pickart, C. The ubiquitin-proteasome pathway in Parkinson's and other neurodegenerative diseases. Trends Cell Biol. (2004).","DOI":"10.1016\/j.tcb.2004.10.006"},{"key":"BFnm1066_CR6","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1056\/NEJM2003ra020003","volume":"348","author":"RL Nussbaum","year":"2003","unstructured":"Nussbaum, R.L. & Ellis, C.E. Alzheimer's disease and Parkinson's disease. N. Engl. J. Med. 348, 1356\u20131364 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnm1066_CR7","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nn0702-633","volume":"5","author":"PC Wong","year":"2002","unstructured":"Wong, P.C., Cai, H., Borchelt, D.R. & Price, D.L. Genetically engineered mouse models of neurodegenerative diseases. Nat. Neurosci. 5, 633\u2013639 (2002).","journal-title":"Nat. Neurosci."},{"key":"BFnm1066_CR8","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/0896-6273(95)90138-8","volume":"15","author":"CA Ross","year":"1995","unstructured":"Ross, C.A. When more is less: pathogenesis of glutamine repeat neurodegenerative diseases. Neuron 15, 493\u2013496 (1995).","journal-title":"Neuron"},{"key":"BFnm1066_CR9","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/nature02264","volume":"426","author":"DJ Selkoe","year":"2003","unstructured":"Selkoe, D.J. Folding proteins in fatal ways. Nature 426, 900\u2013904 (2003).","journal-title":"Nature"},{"key":"BFnm1066_CR10","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","volume":"90","author":"SW Davies","year":"1997","unstructured":"Davies, S.W. et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537\u2013548 (1997).","journal-title":"Cell"},{"key":"BFnm1066_CR11","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1073\/pnas.96.8.4604","volume":"96","author":"E Scherzinger","year":"1999","unstructured":"Scherzinger, E. et al. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology. Proc. Natl. Acad. Sci. USA 96, 4604\u20134609 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1066_CR12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel, J.P. et al. Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44, 559\u2013577 (1985).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnm1066_CR13","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/1531-8249(199912)46:6<842::AID-ANA6>3.0.CO;2-O","volume":"46","author":"S Kuemmerle","year":"1999","unstructured":"Kuemmerle, S. et al. Huntington aggregates may not predict neuronal death in Huntington's disease. Ann. Neurol. 46, 842\u2013849 (1999).","journal-title":"Ann. Neurol."},{"key":"BFnm1066_CR14","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","volume":"19","author":"CA Gutekunst","year":"1999","unstructured":"Gutekunst, C.A. et al. Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J. Neurosci. 19, 2522\u20132534 (1999).","journal-title":"J. Neurosci."},{"key":"BFnm1066_CR15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1006\/nbdi.1998.0168","volume":"4","author":"MW Becher","year":"1998","unstructured":"Becher, M.W. et al. Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length. Neurobiol. Dis. 4, 387\u2013397 (1998).","journal-title":"Neurobiol. Dis."},{"key":"BFnm1066_CR16","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1212\/WNL.38.3.341","volume":"38","author":"RH Myers","year":"1988","unstructured":"Myers, R.H. et al. Clinical and neuropathologic assessment of severity in Huntington disease. Neurology 38, 341\u2013347 (1988).","journal-title":"Neurology"},{"key":"BFnm1066_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S1097-2765(04)00151-0","volume":"14","author":"P Venkatraman","year":"2004","unstructured":"Venkatraman, P., Wetzel, R., Tanaka, M., Nukina, N. & Goldberg, A.L. Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins. Mol. Cell 14, 95\u2013104 (2004).","journal-title":"Mol. Cell"},{"key":"BFnm1066_CR18","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1023\/B:SCAM.0000007124.19463.e5","volume":"24","author":"CC Huang","year":"1998","unstructured":"Huang, C.C. et al. Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins. Somat. Cell Mol. Genet. 24, 217\u2013233 (1998).","journal-title":"Somat. Cell Mol. Genet."},{"key":"BFnm1066_CR19","doi-asserted-by":"publisher","first-page":"11404","DOI":"10.1073\/pnas.96.20.11404","volume":"96","author":"A Kazantsev","year":"1999","unstructured":"Kazantsev, A., Preisinger, E., Dranovsky, A., Goldgaber, D. & Housman, D. Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells. Proc. Natl. Acad. Sci. USA 96, 11404\u201311409 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1066_CR20","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S1471-4914(01)02179-7","volume":"7","author":"RL Margolis","year":"2001","unstructured":"Margolis, R.L. & Ross, C.A. Expansion explosion: new clues to the pathogenesis of repeat expansion neurodegenerative diseases. Trends Mol. Med. 7, 479\u2013482 (2001).","journal-title":"Trends Mol. Med."},{"key":"BFnm1066_CR21","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1093\/hmg\/10.20.2307","volume":"10","author":"HT Orr","year":"2001","unstructured":"Orr, H.T. & Zoghbi, H.Y. SCA1 molecular genetics: a history of a 13 year collaboration against glutamines. Hum. Mol. Genet. 10, 2307\u20132311 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm1066_CR22","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1110\/ps.0224403","volume":"12","author":"S Sen","year":"2003","unstructured":"Sen, S., Dash, D., Pasha, S. & Brahmachari, S.K. Role of histidine interruption in mitigating the pathological effects of long polyglutamine stretches in SCA1: a molecular approach. Protein Sci. 12, 953\u2013962 (2003).","journal-title":"Protein Sci."},{"key":"BFnm1066_CR23","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"DJ Selkoe","year":"2002","unstructured":"Selkoe, D.J. Alzheimer's disease is a synaptic failure. Science 298, 789\u2013791 (2002).","journal-title":"Science"},{"key":"BFnm1066_CR24","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy, J. & Selkoe, D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353\u2013356 (2002).","journal-title":"Science"},{"key":"BFnm1066_CR25","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1006\/jmbi.2000.3650","volume":"299","author":"LC Serpell","year":"2000","unstructured":"Serpell, L.C. & Smith, J.M. Direct visualisation of the \u03b2-sheet structure of synthetic Alzheimer's amyloid. J. Mol. Biol. 299, 225\u2013231 (2000).","journal-title":"J. Mol. Biol."},{"key":"BFnm1066_CR26","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1126\/science.1064638","volume":"293","author":"WP Esler","year":"2001","unstructured":"Esler, W.P. & Wolfe, M.S. A portrait of Alzheimer secretases\u2014new features and familiar faces. Science 293, 1449\u20131454 (2001).","journal-title":"Science"},{"issue":"suppl.","key":"BFnm1066_CR27","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/nn940","volume":"5","author":"M Citron","year":"2002","unstructured":"Citron, M. Alzheimer's disease: treatments in discovery and development. Nat. Neurosci. 5 (suppl.), 1055\u20131057 (2002).","journal-title":"Nat. Neurosci."},{"key":"BFnm1066_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.semcdb.2003.12.015","volume":"15","author":"M Goedert","year":"2004","unstructured":"Goedert, M. Tau protein and neurodegeneration. Semin. Cell Dev. Biol. 15, 45\u201349 (2004).","journal-title":"Semin. Cell Dev. Biol."},{"key":"BFnm1066_CR29","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S1471-4914(02)02440-1","volume":"8","author":"EM Ingram","year":"2002","unstructured":"Ingram, E.M. & Spillantini, M.G. Tau gene mutations: dissecting the pathogenesis of FTDP\u201317. Trends Mol. Med. 8, 555\u2013562 (2002).","journal-title":"Trends Mol. Med."},{"key":"BFnm1066_CR30","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/00005072-199603000-00001","volume":"55","author":"LS Forno","year":"1996","unstructured":"Forno, L.S. Neuropathology of Parkinson's disease. J. Neuropathol. Exp. Neurol. 55, 259\u2013272 (1996).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnm1066_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1172\/JCI200317575","volume":"111","author":"TM Dawson","year":"2003","unstructured":"Dawson, T.M. & Dawson, V.L. Rare genetic mutations shed light on the pathogenesis of Parkinson disease. J. Clin. Invest 111, 145\u2013151 (2003).","journal-title":"J. Clin. Invest"},{"key":"BFnm1066_CR32","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1126\/science.1096284","volume":"304","author":"EM Valente","year":"2004","unstructured":"Valente, E.M. et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304, 1158\u20131160 (2004).","journal-title":"Science"},{"key":"BFnm1066_CR33","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/35097565","volume":"2","author":"DW Cleveland","year":"2001","unstructured":"Cleveland, D.W. & Rothstein, J.D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2, 806\u2013819 (2001).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFnm1066_CR34","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1126\/science.281.5384.1851","volume":"281","author":"LI Bruijn","year":"1998","unstructured":"Bruijn, L.I. et al. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281, 1851\u20131854 (1998).","journal-title":"Science"},{"key":"BFnm1066_CR35","doi-asserted-by":"publisher","first-page":"47551","DOI":"10.1074\/jbc.M207356200","volume":"277","author":"R Rakhit","year":"2002","unstructured":"Rakhit, R. et al. Oxidation-induced misfolding and aggregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis. J. Biol. Chem. 277, 47551\u201347556 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnm1066_CR36","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1056\/NEJM200105173442006","volume":"344","author":"SB Prusiner","year":"2001","unstructured":"Prusiner, S.B. Shattuck lecture\u2014neurodegenerative diseases and prions. N. Engl. J. Med. 344, 1516\u20131526 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFnm1066_CR37","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1098\/rstb.2000.0762","volume":"356","author":"S Lindquist","year":"2001","unstructured":"Lindquist, S., Krobitsch, S., Li, L. & Sondheimer, N. Investigating protein conformation-based inheritance and disease in yeast. Phil. Trans. R. Soc. Lond. B 356, 169\u2013176 (2001).","journal-title":"Phil. Trans. R. Soc. Lond. B"},{"key":"BFnm1066_CR38","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1073\/pnas.0308754101","volume":"101","author":"T Scheibel","year":"2004","unstructured":"Scheibel, T., Bloom, J. & Lindquist, S.L. The elongation of yeast prion fibers involves separable steps of association and conversion. Proc. Natl. Acad. Sci. USA 101, 2287\u20132292 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1066_CR39","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1126\/science.1073725","volume":"298","author":"J Ma","year":"2002","unstructured":"Ma, J., Wollmann, R. & Lindquist, S. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298, 1781\u20131785 (2002).","journal-title":"Science"},{"key":"BFnm1066_CR40","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1126\/science.1073619","volume":"298","author":"J Ma","year":"2002","unstructured":"Ma, J. & Lindquist, S. Conversion of PrP to a self-perpetuating PrPSc-like conformation in the cytosol. Science 298, 1785\u20131788 (2002).","journal-title":"Science"},{"key":"BFnm1066_CR41","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1177\/16.11.673","volume":"16","author":"ED Eanes","year":"1968","unstructured":"Eanes, E.D. & Glenner, G.G. X-ray diffraction studies on amyloid filaments. J. Histochem. Cytochem. 16, 673\u2013677 (1968).","journal-title":"J. Histochem. Cytochem."},{"key":"BFnm1066_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0033583598003400","volume":"31","author":"M Sunde","year":"1998","unstructured":"Sunde, M. & Blake, C.C. From the globular to the fibrous state: protein structure and structural conversion in amyloid formation. Q. Rev. Biophys. 31, 1\u201339 (1998).","journal-title":"Q. Rev. Biophys."},{"key":"BFnm1066_CR43","doi-asserted-by":"publisher","first-page":"13407","DOI":"10.1073\/pnas.95.23.13407","volume":"95","author":"TL Benzinger","year":"1998","unstructured":"Benzinger, T.L. et al. Propagating structure of Alzheimer's \u03b2-amyloid(10\u201335) is parallel \u03b2-sheet with residues in exact register. Proc. Natl. Acad. Sci. USA 95, 13407\u201313412 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1066_CR44","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1021\/bi027378p","volume":"42","author":"R Tycko","year":"2003","unstructured":"Tycko, R. Insights into the amyloid folding problem from solid-state NMR. Biochemistry 42, 3151\u20133159 (2003).","journal-title":"Biochemistry"},{"key":"BFnm1066_CR45","doi-asserted-by":"publisher","first-page":"40810","DOI":"10.1074\/jbc.M205659200","volume":"277","author":"M Torok","year":"2002","unstructured":"Torok, M. et al. Structural and dynamic features of Alzheimer's A\u03b2 peptide in amyloid fibrils studied by site-directed spin labeling. J. Biol. Chem. 277, 40810\u201340815 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnm1066_CR46","doi-asserted-by":"publisher","first-page":"37530","DOI":"10.1074\/jbc.M305266200","volume":"278","author":"A Der-Sarkissian","year":"2003","unstructured":"Der-Sarkissian, A., Jao, C.C., Chen, J. & Langen, R. Structural organization of \u03b1-synuclein fibrils studied by site-directed spin labeling. J. Biol. Chem. 278, 37530\u201337535 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnm1066_CR47","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1021\/bi991527v","volume":"39","author":"TL Benzinger","year":"2000","unstructured":"Benzinger, T.L. et al. Two-dimensional structure of \u03b2-amyloid(10\u201335) fibrils. Biochemistry 39, 3491\u20133499 (2000).","journal-title":"Biochemistry"},{"key":"BFnm1066_CR48","doi-asserted-by":"publisher","first-page":"13748","DOI":"10.1021\/bi0011330","volume":"39","author":"JJ Balbach","year":"2000","unstructured":"Balbach, J.J. et al. Amyloid fibril formation by A\u03b216\u201322, a seven-residue fragment of the Alzheimer's \u03b2-amyloid peptide, and structural characterization by solid state NMR. Biochemistry 39, 13748\u201313759 (2000).","journal-title":"Biochemistry"},{"key":"BFnm1066_CR49","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.jmb.2003.11.008","volume":"335","author":"AD Williams","year":"2004","unstructured":"Williams, A.D. et al. Mapping A\u03b2 amyloid fibril secondary structure using scanning proline mutagenesis. J. Mol. Biol. 335, 833\u2013842 (2004).","journal-title":"J. Mol. Biol."},{"key":"BFnm1066_CR50","doi-asserted-by":"publisher","first-page":"17014","DOI":"10.1073\/pnas.252523899","volume":"99","author":"AK Thakur","year":"2002","unstructured":"Thakur, A.K. & Wetzel, R. Mutational analysis of the structural organization of polyglutamine aggregates. Proc. Natl. Acad. Sci. USA 99, 17014\u201317019 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1066_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1073\/pnas.0237018100","volume":"100","author":"CA Ross","year":"2003","unstructured":"Ross, C.A., Poirier, M.A., Wanker, E.E. & Amzel, M. Polyglutamine fibrillogenesis: the pathway unfolds. Proc. Natl. Acad. Sci. USA 100, 1\u20133 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1066_CR52","doi-asserted-by":"publisher","first-page":"7391","DOI":"10.1021\/bi011772q","volume":"41","author":"S Chen","year":"2002","unstructured":"Chen, S., Berthelier, V., Hamilton, J.B., O'Nuallain, B. & Wetzel, R. Amyloid-like features of polyglutamine aggregates and their assembly kinetics. Biochemistry 41, 7391\u20137399 (2002).","journal-title":"Biochemistry"},{"key":"BFnm1066_CR53","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1073\/pnas.022662599","volume":"99","author":"B O'Nuallain","year":"2002","unstructured":"O'Nuallain, B. & Wetzel, R. Conformational Abs recognizing a generic amyloid fibril epitope. Proc. Natl. Acad. Sci. USA 99, 1485\u20131490 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1066_CR54","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1007\/s00018-003-3096-6","volume":"60","author":"VN Uversky","year":"2003","unstructured":"Uversky, V.N. Protein folding revisited. A polypeptide chain at the folding-misfolding-nonfolding cross-roads: which way to go? Cell Mol. Life Sci. 60, 1852\u20131871 (2003).","journal-title":"Cell Mol. Life Sci."},{"key":"BFnm1066_CR55","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/35018098","volume":"406","author":"G Clarke","year":"2000","unstructured":"Clarke, G. et al. A one-hit model of cell death in inherited neuronal degenerations. Nature 406, 195\u2013199 (2000).","journal-title":"Nature"},{"key":"BFnm1066_CR56","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcdb.2003.12.008","volume":"15","author":"CM Dobson","year":"2004","unstructured":"Dobson, C.M. Principles of protein folding, misfolding and aggregation. Semin. Cell Dev. Biol. 15, 3\u201316 (2004).","journal-title":"Semin. Cell Dev. Biol."},{"key":"BFnm1066_CR57","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nrd769","volume":"1","author":"JC Sacchettini","year":"2002","unstructured":"Sacchettini, J.C. & Kelly, J.W. Therapeutic strategies for human amyloid diseases. Nat. Rev. Drug Discov. 1, 267\u2013275 (2002).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnm1066_CR58","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0896-6273(00)80406-7","volume":"19","author":"PT Lansbury Jr.","year":"1997","unstructured":"Lansbury, P.T., Jr. Structural neurology: are seeds at the root of neuronal degeneration? Neuron 19, 1151\u20131154 (1997).","journal-title":"Neuron"},{"key":"BFnm1066_CR59","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrn1007","volume":"4","author":"C Soto","year":"2003","unstructured":"Soto, C. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat. Rev. Neurosci. 4, 49\u201360 (2003).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFnm1066_CR60","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton, A.B. et al. \u03b1-Synuclein locus triplication causes Parkinson's disease. Science 302, 841 (2003).","journal-title":"Science"},{"key":"BFnm1066_CR61","doi-asserted-by":"publisher","first-page":"R123","DOI":"10.1093\/hmg\/ddh093","volume":"13","author":"A Singleton","year":"2004","unstructured":"Singleton, A., Myers, A. & Hardy, J. The law of mass action applied to neurodegenerative disease: a hypothesis concerning the etiology and pathogenesis of complex diseases. Hum. Mol. Genet. 13 (special no 1), R123\u2013R126 (2004).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm1066_CR62","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1126\/science.1063522","volume":"294","author":"KA Conway","year":"2001","unstructured":"Conway, K.A., Rochet, J.C., Bieganski, R.M. & Lansbury, P.T., Jr. Kinetic stabilization of the \u03b1-synuclein protofibril by a dopamine-\u03b1-synuclein adduct. Science 294, 1346\u20131349 (2001).","journal-title":"Science"},{"key":"BFnm1066_CR63","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1126\/science.290.5493.985","volume":"290","author":"BI Giasson","year":"2000","unstructured":"Giasson, B.I. et al. Oxidative damage linked to neurodegeneration by selective \u03b1-synuclein nitration in synucleinopathy lesions. Science 290, 985\u2013989 (2000).","journal-title":"Science"},{"key":"BFnm1066_CR64","first-page":"1517","volume":"148","author":"T Iwatsubo","year":"1996","unstructured":"Iwatsubo, T. et al. Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease. Am. J. Pathol. 148, 1517\u20131529 (1996).","journal-title":"Am. J. Pathol."},{"issue":"suppl. 3","key":"BFnm1066_CR65","first-page":"III11","volume":"250","author":"T Iwatsubo","year":"2003","unstructured":"Iwatsubo, T. Aggregation of \u03b1-synuclein in the pathogenesis of Parkinson's disease. J. Neurol. 250 (suppl. 3), III11\u2013III14 (2003).","journal-title":"J. Neurol."},{"key":"BFnm1066_CR66","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1074\/jbc.275.1.390","volume":"275","author":"M Okochi","year":"2000","unstructured":"Okochi, M. et al. Constitutive phosphorylation of the Parkinson's disease associated \u03b1-synuclein. J. Biol. Chem. 275, 390\u2013397 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnm1066_CR67","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini, M.G. et al. \u03b1-synuclein in Lewy bodies. Nature 388, 839\u2013840 (1997).","journal-title":"Nature"},{"key":"BFnm1066_CR68","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0896-6273(03)00258-7","volume":"38","author":"ES Emamian","year":"2003","unstructured":"Emamian, E.S. et al. Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice. Neuron 38, 375\u2013387 (2003).","journal-title":"Neuron"},{"key":"BFnm1066_CR69","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1126\/science.1092194","volume":"304","author":"JS Steffan","year":"2004","unstructured":"Steffan, J.S. et al. Modification of Huntingtin and Huntington's disease pathology. Science 304, 100\u2013104 (2004).","journal-title":"Science"},{"key":"BFnm1066_CR70","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia, M. et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990\u20131993 (1997).","journal-title":"Science"},{"key":"BFnm1066_CR71","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","volume":"95","author":"F Saudou","year":"1998","unstructured":"Saudou, F., Finkbeiner, S., Devys, D. & Greenberg, M.E. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95, 55\u201366 (1998).","journal-title":"Cell"},{"key":"BFnm1066_CR72","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1006\/mcne.1999.0773","volume":"14","author":"MF Peters","year":"1999","unstructured":"Peters, M.F. et al. Nuclear targeting of mutant Huntingtin increases toxicity. Mol. Cell Neurosci. 14, 121\u2013128 (1999).","journal-title":"Mol. Cell Neurosci."},{"key":"BFnm1066_CR73","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1523\/JNEUROSCI.22-09-03473.2002","volume":"22","author":"LP de Almeida","year":"2002","unstructured":"de Almeida, L.P., Ross, C.A., Zala, D., Aebischer, P. & Deglon, N. Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length. J. Neurosci. 22, 3473\u20133483 (2002).","journal-title":"J. Neurosci."},{"key":"BFnm1066_CR74","doi-asserted-by":"publisher","first-page":"7862","DOI":"10.1523\/JNEUROSCI.22-18-07862.2002","volume":"22","author":"CL Wellington","year":"2002","unstructured":"Wellington, C.L. et al. Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease. J. Neurosci. 22, 7862\u20137872 (2002).","journal-title":"J. Neurosci."},{"key":"BFnm1066_CR75","doi-asserted-by":"publisher","first-page":"21211","DOI":"10.1074\/jbc.M401267200","volume":"279","author":"J Gafni","year":"2004","unstructured":"Gafni, J. et al. Inhibition of calpain cleavage of Huntingtin reduces toxicity: accumulation of calpain\/caspase fragments in the nucleus. J. Biol. Chem. 279, 21211\u201321220 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnm1066_CR76","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1097-2765(02)00602-0","volume":"10","author":"A Lunkes","year":"2002","unstructured":"Lunkes, A. et al. Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions. Mol. Cell 10, 259\u2013269 (2002).","journal-title":"Mol. Cell"},{"key":"BFnm1066_CR77","doi-asserted-by":"publisher","first-page":"41032","DOI":"10.1074\/jbc.M205809200","volume":"277","author":"MA Poirier","year":"2002","unstructured":"Poirier, M.A. et al. Huntingtin spheroids and protofibrils as precursors in polyglutamine fibrilization. J. Biol. Chem. 277, 41032\u201341037 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnm1066_CR78","doi-asserted-by":"publisher","first-page":"13047","DOI":"10.1074\/jbc.M211224200","volume":"278","author":"FC Nucifora Jr.","year":"2003","unstructured":"Nucifora, F.C., Jr. et al. Nuclear localization of a non-caspase truncation product of atrophin-1, with an expanded polyglutamine repeat, increases cellular toxicity. J. Biol. Chem. 278, 13047\u201313055 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnm1066_CR79","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1021\/bi0356707","volume":"43","author":"EN Lee","year":"2004","unstructured":"Lee, E.N. et al. Phthalocyanine tetrasulfonates affect the amyloid formation and cytotoxicity of \u03b1-synuclein. Biochemistry 43, 3704\u20133715 (2004).","journal-title":"Biochemistry"},{"key":"BFnm1066_CR80","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.tibs.2003.09.009","volume":"28","author":"JN Buxbaum","year":"2003","unstructured":"Buxbaum, J.N. Diseases of protein conformation: what do in vitro experiments tell us about in vivo diseases? Trends Biochem. Sci. 28, 585\u2013592 (2003).","journal-title":"Trends Biochem. Sci."},{"key":"BFnm1066_CR81","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0969-2126(02)00809-2","volume":"10","author":"R Wetzel","year":"2002","unstructured":"Wetzel, R. Ideas of order for amyloid fibril structure. Structure (Camb) 10, 1031\u20131036 (2002).","journal-title":"Structure (Camb)"},{"key":"BFnm1066_CR82","doi-asserted-by":"crossref","first-page":"28551","DOI":"10.1016\/S0021-9258(19)61939-3","volume":"269","author":"B Soreghan","year":"1994","unstructured":"Soreghan, B., Kosmoski, J. & Glabe, C. Surfactant properties of Alzheimer's A\u03b2 peptides and the mechanism of amyloid aggregation. J. Biol. Chem. 269, 28551\u201328554 (1994).","journal-title":"J. Biol. Chem."},{"key":"BFnm1066_CR83","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S1074-5521(97)90303-3","volume":"4","author":"JD Harper","year":"1997","unstructured":"Harper, J.D., Lieber, C.M. & Lansbury, P.T., Jr. Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-\u03b2 protein. Chem. Biol. 4, 951\u2013959 (1997).","journal-title":"Chem. Biol."},{"key":"BFnm1066_CR84","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","volume":"95","author":"MP Lambert","year":"1998","unstructured":"Lambert, M.P. et al. Diffusible, nonfibrillar ligands derived from A\u03b21\u201342 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA 95, 6448\u20136453 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1066_CR85","doi-asserted-by":"publisher","first-page":"8972","DOI":"10.1021\/bi9904149","volume":"38","author":"JD Harper","year":"1999","unstructured":"Harper, J.D., Wong, S.S., Lieber, C.M. & Lansbury, P.T., Jr. Assembly of A\u03b2 amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease. Biochemistry 38, 8972\u20138980 (1999).","journal-title":"Biochemistry"},{"key":"BFnm1066_CR86","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1146\/annurev.biochem.66.1.385","volume":"66","author":"JD Harper","year":"1997","unstructured":"Harper, J.D. & Lansbury, P.T., Jr. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66, 385\u2013407 (1997).","journal-title":"Annu. Rev. Biochem."},{"key":"BFnm1066_CR87","doi-asserted-by":"publisher","first-page":"22364","DOI":"10.1074\/jbc.272.35.22364","volume":"272","author":"DM Walsh","year":"1997","unstructured":"Walsh, D.M., Lomakin, A., Benedek, G.B., Condron, M.M. & Teplow, D.B. Amyloid \u03b2-protein fibrillogenesis. Detection of a protofibrillar intermediate. J. Biol. Chem. 272, 22364\u201322372 (1997).","journal-title":"J. Biol. Chem."},{"key":"BFnm1066_CR88","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0166-2236(00)01749-5","volume":"24","author":"WL Klein","year":"2001","unstructured":"Klein, W.L., Krafft, G.A. & Finch, C.E. Targeting small A\u03b2 oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci. 24, 219\u2013224 (2001).","journal-title":"Trends Neurosci."},{"key":"BFnm1066_CR89","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry, R.D. et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572\u2013580 (1991).","journal-title":"Ann. Neurol."},{"key":"BFnm1066_CR90","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","volume":"46","author":"CA McLean","year":"1999","unstructured":"McLean, C.A. et al. Soluble pool of A\u03b2 amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann. Neurol. 46, 860\u2013866 (1999).","journal-title":"Ann. Neurol."},{"key":"BFnm1066_CR91","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","volume":"155","author":"LF Lue","year":"1999","unstructured":"Lue, L.F. et al. Soluble amyloid \u03b2 peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol. 155, 853\u2013862 (1999).","journal-title":"Am. J. Pathol."},{"key":"BFnm1066_CR92","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/416535a","volume":"416","author":"DM Walsh","year":"2002","unstructured":"Walsh, D.M. et al. Naturally secreted oligomers of amyloid \u03b2 protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535\u2013539 (2002).","journal-title":"Nature"},{"key":"BFnm1066_CR93","doi-asserted-by":"publisher","first-page":"7812","DOI":"10.1021\/bi0102398","volume":"40","author":"MJ Volles","year":"2001","unstructured":"Volles, M.J. et al. Vesicle permeabilization by protofibrillar \u03b1-synuclein: implications for the pathogenesis and treatment of Parkinson's disease. Biochemistry 40, 7812\u20137819 (2001).","journal-title":"Biochemistry"},{"key":"BFnm1066_CR94","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0896-6273(03)00024-2","volume":"37","author":"R Sharon","year":"2003","unstructured":"Sharon, R. et al. The formation of highly soluble oligomers of \u03b1-synuclein is regulated by fatty acids and enhanced in Parkinson's disease. Neuron 37, 583\u2013595 (2003).","journal-title":"Neuron"},{"key":"BFnm1066_CR95","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1006\/jmbi.2001.4850","volume":"311","author":"S Chen","year":"2001","unstructured":"Chen, S., Berthelier, V., Yang, W. & Wetzel, R. Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity. J. Mol. Biol. 311, 173\u2013182 (2001).","journal-title":"J. Mol. Biol."},{"key":"BFnm1066_CR96","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nature01301","volume":"421","author":"I Sanchez","year":"2003","unstructured":"Sanchez, I., Mahlke, C. & Yuan, J. Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders. Nature 421, 373\u2013379 (2003).","journal-title":"Nature"},{"key":"BFnm1066_CR97","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1126\/science.1056784","volume":"291","author":"FC Nucifora Jr.","year":"2001","unstructured":"Nucifora, F.C., Jr. et al. Interference by huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity. Science 291, 2423\u20132428 (2001).","journal-title":"Science"},{"key":"BFnm1066_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/hmg\/ddg002","volume":"12","author":"H Jiang","year":"2003","unstructured":"Jiang, H., Nucifora, F.C., Jr., Ross, C.A. & DeFranco, D.B. Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein. Hum. Mol. Genet. 12, 1\u201312 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm1066_CR99","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1126\/science.292.5521.1552","volume":"292","author":"NF Bence","year":"2001","unstructured":"Bence, N.F., Sampat, R.M. & Kopito, R.R. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292, 1552\u20131555 (2001).","journal-title":"Science"},{"key":"BFnm1066_CR100","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1126\/science.1079469","volume":"300","author":"R Kayed","year":"2003","unstructured":"Kayed, R. et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486\u2013489 (2003).","journal-title":"Science"},{"key":"BFnm1066_CR101","doi-asserted-by":"publisher","first-page":"E51","DOI":"10.1038\/35055162","volume":"3","author":"AJ McClellan","year":"2001","unstructured":"McClellan, A.J. & Frydman, J. Molecular chaperones and the art of recognizing a lost cause. Nat. Cell Biol. 3, E51\u2013E53 (2001).","journal-title":"Nat. Cell Biol."},{"key":"BFnm1066_CR102","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/nature02263","volume":"426","author":"AL Goldberg","year":"2003","unstructured":"Goldberg, A.L. Protein degradation and protection against misfolded or damaged proteins. Nature 426, 895\u2013899 (2003).","journal-title":"Nature"},{"key":"BFnm1066_CR103","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0896-6273(03)00606-8","volume":"40","author":"A Ciechanover","year":"2003","unstructured":"Ciechanover, A. & Brundin, P. The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron 40, 427\u2013446 (2003).","journal-title":"Neuron"},{"key":"BFnm1066_CR104","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0962-8924(00)01852-3","volume":"10","author":"RR Kopito","year":"2000","unstructured":"Kopito, R.R. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 10, 524\u2013530 (2000).","journal-title":"Trends Cell Biol."},{"key":"BFnm1066_CR105","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/ng1362","volume":"36","author":"B Ravikumar","year":"2004","unstructured":"Ravikumar, B. et al. Inhibitor of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 36, 585\u2013595 (2004).","journal-title":"Nat. Genet."},{"key":"BFnm1066_CR106","doi-asserted-by":"publisher","first-page":"4625","DOI":"10.1074\/jbc.M310994200","volume":"279","author":"M Tanaka","year":"2004","unstructured":"Tanaka, M. et al. Aggresomes formed by \u03b1-synuclein and synphilin-1 are cytoprotective. J. Biol. Chem. 279, 4625\u20134631 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnm1066_CR107","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1093\/hmg\/11.22.2689","volume":"11","author":"LG Verhoef","year":"2002","unstructured":"Verhoef, L.G., Lindsten, K., Masucci, M.G. & Dantuma, N.P. Aggregate formation inhibits proteasomal degradation of polyglutamine proteins. Hum. Mol. Genet. 11, 2689\u20132700 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm1066_CR108","doi-asserted-by":"publisher","first-page":"45160","DOI":"10.1074\/jbc.M104873200","volume":"276","author":"KF Winklhofer","year":"2001","unstructured":"Winklhofer, K.F., Reintjes, A., Hoener, M.C., Voellmy, R. & Tatzelt, J. Geldanamycin restores a defective heat shock response in vivo. J. Biol. Chem. 276, 45160\u201345167 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnm1066_CR109","first-page":"1606","volume":"2","author":"PW Piper","year":"2001","unstructured":"Piper, P.W. The Hsp90 chaperone as a promising drug target. Curr. Opin. Investig. Drugs 2, 1606\u20131610 (2001).","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"BFnm1066_CR110","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","volume":"101","author":"A Yamamoto","year":"2000","unstructured":"Yamamoto, A., Lucas, J.J. & Hen, R. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell 101, 57\u201366 (2000).","journal-title":"Cell"},{"key":"BFnm1066_CR111","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S1474-4422(04)00678-7","volume":"3","author":"BL Davidson","year":"2004","unstructured":"Davidson, B.L. & Paulson, H.L. Molecular medicine for the brain: silencing of disease genes with RNA interference. Lancet Neurol. 3, 145\u2013149 (2004).","journal-title":"Lancet Neurol."},{"key":"BFnm1066_CR112","doi-asserted-by":"publisher","first-page":"7195","DOI":"10.1073\/pnas.1231012100","volume":"100","author":"VM Miller","year":"2003","unstructured":"Miller, V.M. et al. Allele-specific silencing of dominant disease genes. Proc. Natl. Acad. Sci. USA 100, 7195\u20137200 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1066_CR113","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1126\/science.1088469","volume":"302","author":"A Monsonego","year":"2003","unstructured":"Monsonego, A. & Weiner, H.L. Immunotherapeutic approaches to Alzheimer's disease. Science 302, 834\u2013838 (2003).","journal-title":"Science"},{"key":"BFnm1066_CR114","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1126\/science.301.5641.1847","volume":"301","author":"MP Mattson","year":"2003","unstructured":"Mattson, M.P. & Chan, S.L. Good and bad amyloid antibodies. Science 301, 1847\u20131849 (2003).","journal-title":"Science"},{"key":"BFnm1066_CR115","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/nature01325","volume":"420","author":"HL Weiner","year":"2002","unstructured":"Weiner, H.L. & Selkoe, D.J. Inflammation and therapeutic vaccination in CNS diseases. Nature 420, 879\u2013884 (2002).","journal-title":"Nature"},{"key":"BFnm1066_CR116","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nm985","volume":"10","author":"M Tanaka","year":"2004","unstructured":"Tanaka, M. et al. Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease. Nat. Med. 10, 148\u2013154 (2004).","journal-title":"Nat. Med."},{"key":"BFnm1066_CR117","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1006\/jsbi.2000.4241","volume":"130","author":"B Bohrmann","year":"2000","unstructured":"Bohrmann, B. et al. Self-assembly of \u03b2-amyloid 42 is retarded by small molecular ligands at the stage of structural intermediates. J. Struct. Biol. 130, 232\u2013246 (2000).","journal-title":"J. Struct. Biol."},{"key":"BFnm1066_CR118","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1074\/jbc.271.8.4086","volume":"271","author":"SJ Wood","year":"1996","unstructured":"Wood, S.J., MacKenzie, L., Maleeff, B., Hurle, M.R. & Wetzel, R. Selective inhibition of A\u03b2 fibril formation. J. Biol. Chem. 271, 4086\u20134092 (1996).","journal-title":"J. Biol. Chem."},{"key":"BFnm1066_CR119","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1006\/jsbi.2000.4245","volume":"130","author":"N Reixach","year":"2000","unstructured":"Reixach, N., Crooks, E., Ostresh, J.M., Houghten, R.A. & Blondelle, S.E. Inhibition of \u03b2-amyloid-induced neurotoxicity by imidazopyridoindoles derived from a synthetic combinatorial library. J. Struct. Biol. 130, 247\u2013258 (2000).","journal-title":"J. Struct. Biol."},{"key":"BFnm1066_CR120","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1073\/pnas.2627988100","volume":"100","author":"BC May","year":"2003","unstructured":"May, B.C. et al. Potent inhibition of scrapie prion replication in cultured cells by bis-acridines. Proc. Natl. Acad. Sci. USA 100, 3416\u20133421 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1066_CR121","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.1074\/jbc.M312262200","volume":"279","author":"Y Cordeiro","year":"2004","unstructured":"Cordeiro, Y., Lima, L.M., Gomes, M.P., Foguel, D. & Silva, J.L. Modulation of prion protein oligomerization, aggregation, and \u03b2-sheet conversion by 4,4'-dianilino-1,1'-binaphthyl-5,5\u2032-sulfonate (bis-ANS). J. Biol. Chem. 279, 5346\u20135352 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnm1066_CR122","doi-asserted-by":"publisher","first-page":"16400","DOI":"10.1073\/pnas.182426599","volume":"99","author":"V Heiser","year":"2002","unstructured":"Heiser, V. et al. Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay. Proc. Natl. Acad. Sci. USA 99, 16400\u201316406 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1066_CR123","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0896-6273(03)00697-4","volume":"40","author":"SK Pollitt","year":"2003","unstructured":"Pollitt, S.K. et al. A rapid cellular FRET assay of polyglutamine aggregation identifies a novel inhibitor. Neuron 40, 685\u2013694 (2003).","journal-title":"Neuron"},{"key":"BFnm1066_CR124","doi-asserted-by":"publisher","first-page":"4625","DOI":"10.1021\/jm030247h","volume":"46","author":"V John","year":"2003","unstructured":"John, V., Beck, J.P., Bienkowski, M.J., Sinha, S. & Heinrikson, R.L. Human \u03b2-secretase (BACE) and BACE inhibitors. J. Med. Chem. 46, 4625\u20134630 (2003).","journal-title":"J. Med. Chem."},{"key":"BFnm1066_CR125","doi-asserted-by":"publisher","first-page":"16742","DOI":"10.1073\/pnas.262663499","volume":"99","author":"AT Petkova","year":"2002","unstructured":"Petkova, A.T. et al. A structural model for Alzheimer's \u03b2-amyloid fibrils based on experimental constraints from solid state NMR. Proc. Natl. Acad. Sci. USA 99, 16742\u201316747 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm1066.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1066","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1066.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:02:34Z","timestamp":1684432954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm1066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":125,"journal-issue":{"issue":"S7","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["BFnm1066"],"URL":"https:\/\/doi.org\/10.1038\/nm1066","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}